F11R and peripheral arterial disease: For instance, in patients with PAD, mRNAs of P‐selectin glycoprotein ligand (SELPG), ICAM1, ITGA6, (F11R), and NF‐κB are all up‐regulated targets of PAD‐specific miRNAs.